[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344981-105":3,"doc-detail-344981-en":81,"detail-sidebar-cat-0-en-105":115},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","enhancing-cancer-prediction-among-people-with-elevated-cea-a-novel-approach-using-cea-levels-and-clinical-risk-scoring","Enhancing Cancer Prediction Among People With Elevated CEA - A Novel Approach Using CEA Levels and Clinical Risk Scoring","","Carcinoembryonic antigen (CEA) is widely measured for cancer monitoring, yet its non-specificity limits its value for primary diagnosis. This study evaluates whether integrating CEA levels with a clinical risk scoring system improves cancer prediction in primary care health check-up participants with elevated CEA (≥5 ng/mL). A multivariable logistic regression model defines the score, assessed with ROC analysis and compared with CEA alone.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/enhancing-cancer-prediction-among-people-with-elevated-cea-a-novel-approach-using-cea-levels-and-clinical-risk-scoring/344981/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/enhancing-cancer-prediction-among-people-with-elevated-cea-a-novel-approach-using-cea-levels-and-clinical-risk-scoring/344981.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why focus on people with elevated CEA levels for cancer prediction?","Question",{"text":63,"@type":64},"CEA is frequently measured in primary care and health check-ups, but it is non-specific. The study targets participants with elevated CEA to test whether better prediction is possible using additional clinical risk information.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the clinical risk scoring system developed?",{"text":68,"@type":64},"The study used a multivariable logistic regression model based on records from general health check-up program participants. The resulting score was evaluated with ROC analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"What improvement did the integrated approach show compared with CEA alone?",{"text":72,"@type":64},"Combining the clinical risk scoring system with CEA levels improved performance, achieving an ROC area under the curve of 0.918 versus 0.825 for CEA levels alone.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344981,1790535748,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":86,"file_id":87,"file_url":88,"file_type":89,"file_size":90,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":91,"language":92,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":93,"faqs":94,"seo_title":95,"seo_description":12,"update_tm":96,"read_time":97,"preview_page_count":33,"preview_urls":98},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Enhancing Cancer Prediction Among People With Elevated CEA: A Novel Approach Using CEA Levels and Clinical Risk Scoring  \nJournal of Primary Care & Community Health Volume 17: 1–9 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/21501319261429661](DOI: 10.1177/21501319261429661)[ ](DOI: 10.1177/21501319261429661)[journals.sagepub.com/home/jpc](journals.sagepub.com/home/jpc)  \nNithi Thinrungroj 1, Sirikanya Wisetkupt 1, Kanokporn Pinyopornpanish2,3, Songporn Oranratnachai4, Kanokwan Pinyopornpanish 1,3,  \nand Chaisiri Angkurawaranon 1  \nAbstract  \nIntroduction: Carcinoembryonic antigen (CEA) is a blood biomarker with significance in cancer monitoring and prognosis prediction. Despite not being a primary diagnostic tumor marker, it is frequently measured in clinical practice and health check-ups in primary care services, often prompting extensive investigations due to its non-specific nature. This study investigated the integration of CEA levels with a clinical risk scoring system to enhance cancer prediction in individuals with elevated CEA.  \nMethods: We retrospectively reviewed records, focusing on people who participated in general health check-up programs. Participants with elevated CEA levels ( ≥5 ng/mL) and no previous cancer diagnosis were selected. A multivariable logistic regression model was employed to establish the risk scoring system, which was then evaluated using Receiver Operating Characteristic (ROC) analysis.  \nResults: Among 17 859 participants, 310 had elevated CEA levels, with 7.40% subsequently diagnosed with cancer, primarily colorectal cancer. Combining the clinical risk scoring system with CEA levels significantly improved cancer prediction, with an Area under the ROC curve of 0.918, compared to 0.825 for CEA levels alone.  \nConclusion: CEA, alongside clinical risk prediction, shows promise in predicting cancer among individuals with high CEA levels. This integrated approach can optimize early cancer detection strategies and improve patient outcomes.  \nKeywords  \ncarcinoembryonic antigen, cancer, prediction, clinical risk score, screening  \nReceived: November 20, 2025; revised: February 13, 2026; accepted: February 16, 2026  \nBackground  \nRoutine health check-ups, a key component of the primary care mission to promote health and prevent disease, frequently incorporate cancer screening strategies, acknowledging the well-established benefits of early detection in improving treatment outcomes, particularly during the presymptomatic phase of malignancy.1 Effective treatment outcomes are notably higher during the asymptomatic stage of cancer, preceding symptom onset. Non-invasive and costeffective, blood biomarker tests represent a viable option. For clinical utility, biomarker tests necessitate high predictive accuracy, ease of measurement, reproducibility, and acceptance among patients and healthcare providers.2,3  \nCarcinoembryonic antigen (CEA) is a glycoprotein  \n1 Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand 2Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand  \n3Global Health and Chronic Conditions Research Group, Chiang Mai University, Chiang Mai, Thailand  \n4Sriphat Medical Center, Faculty of medicine, Chiang Mai University, Chiang Mai, Thailand  \nCorresponding Author:  \nKanokporn Pinyopornpanish, Department of Family Medicine, Faculty of Medicine, Chiang Mai University, 110 Inthawarorot Road, Sriphum, Muang, Chiang Mai, 50200, Thailand.  \nEmail: [kpinyopo@gmail.com](kpinyopo@gmail.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commerc","cbCaim1mKrmOa0Od","https://ap.wps.com/l/cbCaim1mKrmOa0Od","pdf",855495,9,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusion\n# Background","[{\"question\":\"Why focus on people with elevated CEA levels for cancer prediction?\",\"answer\":\"CEA is frequently measured in primary care and health check-ups, but it is non-specific. The study targets participants with elevated CEA to test whether better prediction is possible using additional clinical risk information.\"},{\"question\":\"How was the clinical risk scoring system developed?\",\"answer\":\"The study used a multivariable logistic regression model based on records from general health check-up program participants. The resulting score was evaluated with ROC analysis.\"},{\"question\":\"What improvement did the integrated approach show compared with CEA alone?\",\"answer\":\"Combining the clinical risk scoring system with CEA levels improved performance, achieving an ROC area under the curve of 0.918 versus 0.825 for CEA levels alone.\"}]","Enhancing Cancer Prediction Among People With Elevated CEA - A Novel Approach Using CEA Levels and Clinical Risk Scoring | PDF",1790056089,23,[99,103,107,111],{"page_no":22,"url":100,"width":101,"height":102},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a397cfc4b8e0cb24182c5435dfea940.webp",983,1276,{"page_no":26,"url":104,"width":105,"height":106},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ad9293c3a2a9a1df0d0538fc77dc3a6.webp",982,1275,{"page_no":30,"url":108,"width":109,"height":110},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42f2b8c92ecfc85cb7a8d7ea94837b8d.webp",981,1273,{"page_no":33,"url":112,"width":113,"height":114},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e492ab5b80e1be010dfbd27dced79ae.webp",980,1272,{"code":4,"msg":82,"data":116},[117,121,125,129,134,139,144,147,151,154,158],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":118,"show_sort_weight":119,"slug":120},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":122,"show_sort_weight":123,"slug":124},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":126,"show_sort_weight":127,"slug":128},"Exam",70,"exam",{"id":130,"doc_module":4,"doc_module_name":25,"category_name":131,"show_sort_weight":132,"slug":133},5,"Comic",60,"comic",{"id":135,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},6,"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":91,"doc_module":4,"doc_module_name":25,"category_name":148,"show_sort_weight":149,"slug":150},"Religion & Spirituality",20,"religion-spirituality",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":152,"show_sort_weight":149,"slug":153},"World Cup","world-cup",{"id":155,"doc_module":4,"doc_module_name":25,"category_name":156,"show_sort_weight":155,"slug":157},10,"Lifestyle","lifestyle",{"id":159,"doc_module":4,"doc_module_name":25,"category_name":160,"show_sort_weight":130,"slug":161},19,"General","general"]